2013
DOI: 10.1186/1471-230x-13-26
|View full text |Cite
|
Sign up to set email alerts
|

2D ultrasonography and contrast enhanced ultrasound for the evaluation of cavitating mesenteric lymph node syndrome in a patient with refractory celiac disease and enteropathy T cell lymphoma

Abstract: BackgroundThe cavitating mesenteric lymph node syndrome (CMLNS) is a rare manifestation of celiac disease, with an estimated mortality rate of 50%. Specific infections and malignant lymphoma may complicate its clinical course and contribute to its poor prognosis. Diagnosing the underlying cause of CMLNS can be challenging. This is the first report on contrast enhanced ultrasound (CEUS) findings in enteropathy associated T-cell lymphoma (EATL) complicating CMLNS in a gluten-free compliant patient with persisten… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
4
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 20 publications
1
4
0
Order By: Relevance
“…These conclusions are in line with the recommendations of the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) [48]. A rare manifestation of CD was described, namely: the cavitating mesenteric lymph node syndrome with an estimated mortality rate of 50% [49]. Mosteanu et al proposed spiral enteroscopy for patients who are developing complications during CD follow-up [50].…”
Section: Diagnosis Approachsupporting
confidence: 69%
“…These conclusions are in line with the recommendations of the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) [48]. A rare manifestation of CD was described, namely: the cavitating mesenteric lymph node syndrome with an estimated mortality rate of 50% [49]. Mosteanu et al proposed spiral enteroscopy for patients who are developing complications during CD follow-up [50].…”
Section: Diagnosis Approachsupporting
confidence: 69%
“…This, however, may underestimate the true mortality due to limited follow‐up in some reports (median reported follow‐up (months): 12, mean: 17, range 0–72). Lymphoma was diagnosed in 7 patients (24%) including 5 cases reported since 2008 which may reflect a recent increase in awareness for this significant complication and/or increasing use of ancillary techniques for lymphoma diagnosis.…”
Section: Discussionmentioning
confidence: 99%
“…In the first case, the CMLNS and EATL developed in a CD patient with persisting symptoms, despite adherence to the gluten-free diet. 5 The second patient…”
Section: Discussionmentioning
confidence: 99%